Diffuse Neonatal Hemangiomatosis with Unilateral Cranial Nerve Palsy Improved by Propranolol
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Diffuse neonatal hemangiomatosis (DNH) is characterized by multiple capillary or cavernous hemangiomas on the skin and internal organs occurring during the neonatal period. It is a life-threatening condition due to high-output heart failure with a mortality rate of 60-85% without proper treatment. The areas that are most commonly involved include the skin (100%), liver (64-100%), and central nervous system (52%). Corticosteroids are the drugs of choice as an initial treatment and have a response rate of 30-60%. We present here a case of a newborn baby with multiple hemangiomas on her skin (scalp, lips, neck, back, shoulder, arm, buttock, and leg), brain (right cerebellum, pons, and medulla oblongata), lungs, liver, kidney, and bones. She suffered from 6th, 7th, 9th, 10th, and 12th cranial nerve palsy resulting from hemorrhage of the hemangiomas in the brain. The first-line treatment of prednisolone (4 mg/kg/day) was not effective and propranolol (2 mg/kg/day) was administered as a second-line treatment. After 2 weeks of treatment, the hemangiomas had decreased in size with no associated acute hemorrhage. The infant is now 10 months old and both the multiple hemangiomas and cranial nerve palsy have improved. Propranolol was effective without significant adverse effects in treating DNH resistant to corticosteroids.
Abstract
Diffuse neonatal hemangiomatosis (DNH) is characterized by multiple capillary or cavernous hemangiomas on the skin and internal organs occurring during the neonatal period. It is a life-threatening condition due to high-output heart failure with a mortality rate of 60-85% without proper treatment. The areas that are most commonly involved include the skin (100%), liver (64-100%), and central nervous system (52%). Corticosteroids are the drugs of choice as an initial treatment and have a response rate of 30-60%. We present here a case of a newborn baby with multiple hemangiomas on her skin (scalp, lips, neck, back, shoulder, arm, buttock, and leg), brain (right cerebellum, pons, and medulla oblongata), lungs, liver, kidney, and bones. She suffered from 6th, 7th, 9th, 10th, and 12th cranial nerve palsy resulting from hemorrhage of the hemangiomas in the brain. The first-line treatment of prednisolone (4 mg/kg/day) was not effective and propranolol (2 mg/kg/day) was administered as a second-line treatment. After 2 weeks of treatment, the hemangiomas had decreased in size with no associated acute hemorrhage. The infant is now 10 months old and both the multiple hemangiomas and cranial nerve palsy have improved. Propranolol was effective without significant adverse effects in treating DNH resistant to corticosteroids.
참고문헌 (20)
- Gottschling S, "Two infants with life-threatening diffuse neonatal hemangiomatosis treated with cyclophosphamide", Pediatr Blood Cancer, 46, pp.239~242 (2006)
- Dotan M, "Congestive heart failure with diffuse neonatal hemangiomatosis - case report and literature review", Acta Paediatr, 102, pp.e232~e238 (2013)
- Castello MA, "Successful management with interferon alpha-2a after prednisone therapy failure in an infant with a giant cavernous hemangioma", Med Pediatr Oncol, 28, pp.213~215 (1997)
- Perez-Valle S, "Vincristine, an efficacious alternative for diffuse neonatal haemangiomatosis", Acta Paediatr, 99, pp.311~315 (2010)
- Zhou H, "Successful treatment of diffuse neonatal hemangiomatosis with propranolol:a case report", J Dtsch Dermatol Ges, 12, pp.625~628 (2014)
- Park EA, "Infantile hemangioendothelioma treated with high dose methylprednisolone pulse therapy", J Korean Med Sci, 16, pp.127~129 (2001)
- Kim HJ, "Diffuse neonatal hemangiomatosis", Korean J Dermatol, 15, pp.17~20 (2003)
- 이학성, "Successful Management with Vincristine after Failure of Prednisolone Therapy for Diffuse Neonatal Hemangiomatosis", Korean Journal of Pediatrics, 48(9), pp.1004~1008 (2005), 대한소아과학회
- Cho HJ, "A case of diffuse neonatal henangiomatosis improved with prednisolone and interferon alfa-2a", Korean J Dermatol, 34, pp.1039~1043 (1996)
- Seo YW, "Diffuse neonatal hemangiomatosis successfully treated with high dose corticosteroid", Korean J Dermatol, 10, pp.112~115 (1998)
- Park JH, "A case of diffuse neonatal hemangiomatosis", Korean J Dermatol, 39, pp.617~620 (2001)
- Frieden IJ, "Guidelines of care for hemangiomas of infancy", J Am Acad Dermatol, 37, pp.631~637 (1997)
- George ME, "Adverse effects of systemic glucocorticosteroid therapy in infants with hemangiomas", Arch Dermatol, 140, pp.963~969 (2004)
- Nako Y, "Successful interferon therapy in a neonate with life-threatening Kasabach-Merritt syndrome", J Perinatol, 17, pp.244~247 (1997)
- Maya J, "Diffuse neonatal hemangiomatosis", Bol Med Hosp Infant Mex, 70, pp.38~43 (2013)
- Enjolras O, "Vincristine treatment for function- and life-threatening infantile hemangioma", Arch Pediatr, 11, pp.99~107 (2004)
- Hurvitz SA, "Successful treatment with cyclophosphamide of life-threatening diffuse hemangiomatosis involving the liver", J Pediatr Hematol Oncol, 22, pp.527~532 (2000)
- Ferrandiz L, "Diffuse neonatal hemangiomatosis with partial response to propranolol", Int J Dermatol, 53, pp.e247~e250 (2014)
- Holmes WJ, "Propranolol as firstline treatment for rapidly proliferating infantile haemangiomas", J Plast Reconstr Aesthet Surg, 64, pp.445~451 (2011)
- 김영돈, "Timolol 국소 도포를 이용한 영아 혈관종 치험 3례", Neonatal medicine, 21(2), pp.138~143 (2014), 대한신생아학회